横隔膜ペーシング療法システム市場- 世界の産業規模、シェア、動向、機会、予測、製品別、用途別、地域別、競合別、2020-2030F

横隔膜ペーシング療法システムの世界市場規模は2024年に77億1,000万米ドルとなり、予測期間では2030年までCAGR 4.06%で目覚ましい成長が予測されています。

世界の横隔膜ペーシング療法システム市場は、呼吸器疾患の有病率の上昇、医療機器の技術進歩、特定の患者集団の代替療法としての横隔膜ペーシングに対する認知度の向上などの要因によって、近年着実な成長を遂げています。例えば、欧州では、呼吸器疾患は欧州環境庁加盟国の死因の第3位にランクされています。年間約42万人が呼吸器疾患で死亡しており、その60％以上が慢性呼吸器疾患（CRD）に関連している（Eurostat, 2024a;WHO, 2024;IHME, 2024）。呼吸器疾患による死亡率や疾病負担が高い国がある一方で、一貫した地域的パターンは確認されていないです。

市場促進要因

呼吸器疾患の有病率の上昇

主な市場課題

初期コストの高さ

主な市場動向

デバイス技術の強化

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の横隔膜ペーシング療法システム市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（外膜ペースメーカー、横隔膜ペースメーカー）
  • 用途別（脊髄損傷、筋萎縮性側索硬化症、その他）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • 製品別
  • 用途別
  • 地域別

第6章 北米の横隔膜ペーシング療法システム市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の横隔膜ペーシング療法システム市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域の横隔膜ペーシング療法システム市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米の横隔膜ペーシング療法システム市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの横隔膜ペーシング療法システム市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• LUNGPACER MEDICAL INC.
• Avery Biomedical Devices, Inc.
• Synapse Biomedical Inc
• Astrotech Corp
• AstraZeneca PLC
• Novartis AG
• Boehringer Ingelheim
• Respironics Ltd
• Johnson & Johnson（Actelion）
• PneumRx, LLC

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Diaphragm Pacing Therapy System Market was valued at USD 7.71 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 4.06% through 2030. The Global Diaphragm Pacing Therapy System Market has witnessed steady growth in recent years, driven by factors such as the rising prevalence of respiratory disorders, technological advancements in medical devices, and increasing awareness about diaphragm pacing as an alternative therapy for certain patient populations. For instance, in Europe, respiratory disorders rank as the third leading cause of death in European Environment Agency member countries. Annually, nearly 420,000 deaths are attributed to respiratory diseases, with over 60% linked to Chronic Respiratory Diseases (CRDs) (Eurostat, 2024a; WHO, 2024; IHME, 2024). While certain countries experience higher mortality and disease burden from respiratory conditions, no consistent regional pattern has been identified.

Key Market Drivers

Rising Prevalence of Respiratory Disorders

The global healthcare landscape is witnessing a significant shift, with a concerning increase in the prevalence of respiratory disorders. These conditions can significantly impair an individual's ability to breathe, leading to a reduced quality of life and, in severe cases, life-threatening situations. However, amidst these challenges, there is a glimmer of hope for patients in the form of diaphragm pacing therapy systems. As the prevalence of respiratory disorders continues to rise, the diaphragm pacing therapy system market is poised for substantial growth. According to WHO, chronic obstructive pulmonary disease (COPD) claims over 3 million lives annually, silently impacting more than 380 million people worldwide. As the fourth leading cause of death globally, COPD has remained underrepresented in global health discussions, despite its profound effects on patients and families. It's time to bring this noncommunicable disease to the forefront and address its devastating impact.

Key Market Challenges

High Initial Costs

One of the most prominent challenges in the diaphragm pacing therapy system market is the high initial costs associated with these devices. The sophisticated technology and intricate surgical procedures required for implantation can result in substantial expenses for both healthcare facilities and patients. The cost may act as a deterrent, limiting access to those who may benefit from diaphragm pacing therapy.

Key Market Trends

Enhanced Device Technology

One of the most prominent trends in the diaphragm pacing therapy system market is the ongoing enhancement of device technology. Manufacturers are investing in research and development to create more advanced, efficient, and patient-friendly systems. This includes devices with improved battery life, wireless connectivity for remote monitoring, and more compact designs for enhanced comfort.

Key Market Players

• LUNGPACER MEDICAL INC.
• Avery Biomedical Devices, Inc.
• Synapse Biomedical Inc
• Astrotech Corp.
• AstraZeneca PLC
• Novartis AG
• Boehringer Ingelheim
• Respironics Ltd
• Johnson & Johnson (Actelion)
• PneumRx, LLC

Report Scope:

In this report, the Global Diaphragm Pacing Therapy System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diaphragm Pacing Therapy System Market, By Product:

• External Diaphragm Pacemaker
• Diaphragm Pacemaker

Diaphragm Pacing Therapy System Market, By Application:

• Spinal Cord Injury
• Amyotrophic Lateral Sclerosis
• Others

Diaphragm Pacing Therapy System Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diaphragm Pacing Therapy System Market.

Available Customizations:

Global Diaphragm Pacing Therapy System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diaphragm Pacing Therapy System Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 5.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product
  • 5.3.2. By Application
  • 5.3.3. By Region

6. North America Diaphragm Pacing Therapy System Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 6.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diaphragm Pacing Therapy System Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Diaphragm Pacing Therapy System Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Diaphragm Pacing Therapy System Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Diaphragm Pacing Therapy System Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 7.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Diaphragm Pacing Therapy System Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Diaphragm Pacing Therapy System Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. France Diaphragm Pacing Therapy System Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Diaphragm Pacing Therapy System Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Diaphragm Pacing Therapy System Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia-Pacific Diaphragm Pacing Therapy System Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 8.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Diaphragm Pacing Therapy System Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. Japan Diaphragm Pacing Therapy System Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. India Diaphragm Pacing Therapy System Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. Australia Diaphragm Pacing Therapy System Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. South Korea Diaphragm Pacing Therapy System Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. South America Diaphragm Pacing Therapy System Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 9.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Diaphragm Pacing Therapy System Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Diaphragm Pacing Therapy System Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Diaphragm Pacing Therapy System Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Diaphragm Pacing Therapy System Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker)
  • 10.2.2. By Application (Spinal Cord Injury, Amyotrophic Lateral Sclerosis, Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Diaphragm Pacing Therapy System Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Diaphragm Pacing Therapy System Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Diaphragm Pacing Therapy System Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
  • 10.3.4. Kuwait Diaphragm Pacing Therapy System Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Product
      • 10.3.4.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. LUNGPACER MEDICAL INC.
• 14.2. Avery Biomedical Devices, Inc.
• 14.3. Synapse Biomedical Inc
• 14.4. Astrotech Corp
• 14.5. AstraZeneca PLC
• 14.6. Novartis AG
• 14.7. Boehringer Ingelheim
• 14.8. Respironics Ltd
• 14.9. Johnson & Johnson (Actelion)
• 14.10. PneumRx, LLC

15. Strategic Recommendations

16. About Us & Disclaimer